The global Extracorporeal Membrane Oxygenation Market was valued at US$ 294.2 million in 2021 and it is anticipated to grow up to US$ 411.3 million by 2031, at a CAGR of 7.4% during the forecast period.
Extracorporeal life support is another term for extracorporeal membrane oxygenation. It is a life-sustaining system that helps patients with severe respiratory failure by providing respiratory and cardiac support. Lung and heart diseases affect a large number of people in densely populated countries like China and India. This is expected to provide numerous opportunities for industry growth in these countries. According to the most recent data published by the World Health Organization in 2020, lung disease accounts for approximately 10% of all deaths in India. As a result of an increasing number of patients suffering from pulmonary disorders, advanced ECMO devices will become more widely used.
To Remain ‘Ahead’ Of Your Competitors, Request for A Sample – https://www.globalinsightservices.com/request-sample/GIS24315
Major Players in the Global Extracorporeal Membrane Oxygenation Market
The key players studied in the global Extracorporeal Membrane Oxygenation Market are Abiomed (US), Braile Biomedica (Brazil), Fresenius Medical care AG & Co. KGaA (Germany), Getinge Group (Sweden), LivaNova (UK), Medos Medizintechnik AG (Germany), Medtronic (Ireland), Microport Scientific Corporation (China), Nipro Medical Corporation (Japan), and Terumo Cardiovascular Systems Corporation (US) among others.
Global Extracorporeal Membrane Oxygenation Market Segmentation
By Component
- Pumps
- Oxygenator
- Controllers
- Cannula
- Accessories
By Modality
- Veno-Arterial
- Veno-Venous
- Arterio-Venous
Get Customized Report as Per Your Requirement – https://www.globalinsightservices.com/request-customization/GIS24315
Market Drivers and Trends
The rising awareness of the ECMO devices. Increasing patient awareness of the importance of cardiopulmonary assistance for severe cardiac and respiratory conditions will hasten ECMO therapy adoption. The introduction of patient education programs about the ECMO device and its use in emerging economies has resulted in an increase in demand. For example, the Latina Preventive Heart Disease program was launched in Latin America with the goal of raising awareness about advanced therapies and instruments for CVD diseases. Such initiatives aided the growth of the ECMO industry in this region.
Furthermore, Increase of survival rates by using ECMO. ECMO patient survival rates vary depending on the underlying condition and patient’s age. VV-ECMO is indicated for patients with potentially reversible respiratory failure. Patients with respiratory failure who receive VV-ECMO have a higher chance of survival. Because of their ability to support failing cardiovascular systems with oxygenation functions, ECMO machines are also used in cardiac applications. The above aforementioned factors can increase the market growth.
For In-Depth Competitive Analysis, Purchase this Report – https://www.globalinsightservices.com/request-customization/GIS24315
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm
headquartered in Delaware, US. We are committed to providing our clients
with highest quality data, analysis, and tools to meet all their market research
needs. With GIS, you can be assured of the quality of the deliverables, robust
and transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700